Inicio › Cáncer de seno › California › Santa Monica
Ensayos clínicos de Cáncer de seno en Santa Monica, CA
28 estudios para Cáncer de seno buscan participantes en centros de Santa Monica y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
ReclutandoFase 3
- Beverly Hills Cancer Center, Beverly Hills · A 6 mi de distancia
A Study of PHST001 in Advanced Solid Tumors
ReclutandoFase 1
- Precision NextGen Oncology & Research Center, Beverly Hills · A 6 mi de distancia
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
ReclutandoFase 2
- Beverly Hills Cancer Center, Beverly Hills · A 6 mi de distancia
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
ReclutandoFase 1
- Research Site, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Kivu Trial Site, Santa Monica
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Reclutando
- UCLA David Geffen School of Medicine, Santa Monica
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
ReclutandoFase 1
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills · A 6 mi de distancia
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
ReclutandoFase 3
- Clinical Trial Site, Beverly Hills · A 6 mi de distancia
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
ReclutandoFase 1
- University of California, Los Angeles (UCLA), Santa Monica
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
ReclutandoFase 3
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
ReclutandoFase 2
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
ReclutandoFase 1/2
- Beverly Hills Cancer Center, Beverly Hills · A 6 mi de distancia
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
ReclutandoFase 3
- Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ReclutandoFase 3
- Cedars-Sinai Cancer Beverly Hills, Beverly Hills · A 6 mi de distancia
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
ReclutandoFase 1/2
- Research Site, Santa Monica
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
ReclutandoFase 2
- UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
ReclutandoFase 3
- St. John's Cancer Center, Santa Monica
- UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
- UCLA-Hetamtology/Oncology_S Monica, Santa Monica
- y 1 más
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
ReclutandoFase 3
- Tower Cancer Research Foundation, Beverly Hills · A 6 mi de distancia
- Cedars-Sinai Cancer - Tarzana, Tarzana · A 11 mi de distancia
- Kaiser Permanente-Woodland Hills, Woodland Hills · A 12 mi de distancia
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
ReclutandoFase 1
- Precision Next Gen Oncology & Research Center, Beverly Hills · A 6 mi de distancia
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
ReclutandoFase 2
- CS Cancer at Valley Oncology Medical Group, Tarzana · A 11 mi de distancia
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
ReclutandoFase 3
- University of California Los Angeles - Hematology / Oncology Parkside, Santa Monica
E-Mindfulness Approaches for Living After Breast Cancer
ReclutandoFase 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · A 12 mi de distancia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
ReclutandoFase 2
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · A 4 mi de distancia
- Precision NextGen Oncology & Research Center, Beverly Hills · A 6 mi de distancia
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
ReclutandoFase 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
ReclutandoFase 1
- University of California, Los Angeles, Santa Monica
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
ReclutandoFase 3
- Cedars-Sinai Cancer - Tarzana, Tarzana · A 11 mi de distancia
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
ReclutandoFase 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
ReclutandoEstudio observacional
- John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica
Más información sobre Cáncer de seno en MedlinePlus
Ensayos de Cáncer de seno en otras ciudades
- New York City, NY136 estudios
- Houston, TX126 estudios
- Boston, MA112 estudios
- Nashville, TN81 estudios
- Los Angeles, CA73 estudios
- Edison, NJ68 estudios
- St. Louis, MO64 estudios
- Queens, NY64 estudios
- Durham, NC64 estudios
- Chicago, IL59 estudios
- Philadelphia, PA56 estudios
- Dallas, TX55 estudios
Otros estudios en Santa Monica
- Cáncer de pulmón de células no pequeñas45 estudios
- Cáncer del colon y del recto23 estudios
- Cáncer (todos los tipos)22 estudios
- Cáncer metastásico19 estudios
- Cáncer de pulmón15 estudios
- Cáncer de ovario15 estudios
- Cáncer de próstata15 estudios
- Carcinoma de células escamosas de cabeza y cuello13 estudios
- Fallo cardíaco11 estudios
- Cáncer de endometrio10 estudios
- Cáncer de estómago9 estudios
- Cáncer de páncreas9 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.